BREAKING

Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 2 days ago Zoom Communications Q4 2025 Earnings Results 3 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 3 days ago Synopsys Q1 2026 Earnings Results 3 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 3 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 3 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 4 days ago Earnings Preview: Best Buy (BBY) expected to report lower earnings in Q4 2026 5 days ago Apple Inc. (AAPL) Surges 5.1% — Developing Story 5 days ago Mastercard Incorporated (MA) Drops 5.6% — Developing Story 5 days ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 2 days ago Zoom Communications Q4 2025 Earnings Results 3 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 3 days ago Synopsys Q1 2026 Earnings Results 3 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 3 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 3 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 4 days ago Earnings Preview: Best Buy (BBY) expected to report lower earnings in Q4 2026 5 days ago Apple Inc. (AAPL) Surges 5.1% — Developing Story 5 days ago Mastercard Incorporated (MA) Drops 5.6% — Developing Story 5 days ago

ADVERTISEMENT

Market News

Abbott Laboratories (ABT) Q4 2020 Earnings Call

Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021. Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing and Acquisitions Robert B. Ford — President and Chief Executive Officer Robert E. Funck — Executive Vice President, Finance and Chief Financial Officer Analysts: Bob Hopkins — Bank of America Merrill Lynch — Analyst Matthew Taylor — UBS — Analyst Robert Marcus — J.P. Morgan — […]

$ABT January 27, 2021 1 min read

NYSE

$ABT · Earnings

“
Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021. Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing and Acquisitions Robert B. Ford — President and Chief Executive Officer Robert E. Funck — Executive Vice President, Finance and Chief Financial Officer Analysts: Bob Hopkins — Bank of America Merrill Lynch — Analyst Matthew Taylor — UBS — Analyst Robert Marcus — J.P. Morgan — […]
· January 27, 2021

Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021.

Scott Leinenweber — Vice President, Investor Relations, Licensing and Acquisitions

Corporate Participants:

Robert B. Ford — President and Chief Executive Officer

Robert E. Funck — Executive Vice President, Finance and Chief Financial Officer

Analysts:

Bob Hopkins — Bank of America Merrill Lynch — Analyst

ADVERTISEMENT

Matthew Taylor — UBS — Analyst

Robert Marcus — J.P. Morgan — Analyst

David Lewis — Morgan Stanley — Analyst

Lawrence Biegelsen — Wells Fargo — Analyst

Joanne Wuensch — Citi — Analyst

ADVERTISEMENT

Vijay Kumar — Evercore ISI — Analyst

_________
To read the full earnings call transcript, click here

ADVERTISEMENT